Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Callitas Health Inc MPHMF

Callitas Health Inc is a Canada-based company that is primarily engaged in integrated clinical-stage pharmaceutical development and over-the-counter (OTC) consumer goods marketing. The Company provides biomedical technologies and products. The Company offers drug treatments for obesity, infertility, intimacy issues, weight management, female sexual dysfunction solutions and women wellness.


GREY:MPHMF - Post by User

Bullboard Posts
Comment by YoloRoloon May 31, 2017 4:36pm
83 Views
Post# 26307983

RE:Got me too many times.

RE:Got me too many times. I"m eating my words, NOM NOM NOM NOM NOM.  
Good job MQ for releasing the FDA in May, you got me there. 

YoloRolo wrote: Got me here,
The USPTO has issued an Office Action on the patent application for the “Dual Compartment Capsule for the Administration of Orlistat”. This is a common occurrence with applications. We responded to their questions on January 26, 2017 and should have an update sometime in March, 2017. This patent is not required to commercialize 
C-103, but would provide an additional level of patent protection.
Read more at https://www.stockhouse.com/news/press-releases/2017/02/10/m-pharmaceutical-inc-provides-strategic-report-to-shareholders-highlighting#E1byY0cgQl4SCLuD.99
Failed!!

Got me there
M Pharma purchased the website domain www.toconceive.com
Online sales should launch in late April or May, 2017 with targeted sales of 2,000 units per month initially.
Read more at https://www.stockhouse.com/news/press-releases/2017/02/10/m-pharmaceutical-inc-provides-strategic-report-to-shareholders-highlighting#E1byY0cgQl4SCLuD.99
Failed!!!

A lot was suppose to happen this month but it was a no show.  Would have been best for company to not mention any dates at all. 
And where's the Vee-Jay cream?

Good Luck to everybody. 

YRolo


Bullboard Posts